Navigation Links
Concord Medical to Report Fourth Quarter and Fiscal Year 2010 Financial Results on Monday, March 28, 2011
Date:3/18/2011

BEIJING, March 18, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical") (NYSE: CCM), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2010, before the U.S. market opens on March 28, 2011. Concord Medical's management will hold an earnings conference call at 8 AM on March 28, 2011 U.S. Eastern Time (8 PM on March 28, 2011 Beijing/Hong Kong time).

Dial-in details for the earnings conference call are as follows:US:

+1.866.202.3048China:

+10-800-852-1490 China Netcom (South China)+10-800-152-1490 China Telecom (North China)+10-800-130-0399 China Telecom (South China)Hong Kong:

+800 96 3844UK:

+44 2073658425International:+1.617.213.8843Passcode:

97544973A replay of the conference call may be accessed by phone at the following number until April 4, 2011:

US:

+1-888-286-8010International:+1-617-801-6888Passcode:

93821317Additionally, a live and archived webcast of this conference call will be available at http://ir.cmsholdings.com/.

About Concord Medical

Concord Medical operates the largest network of radiotherapy and diagnostic imaging centers in China in terms of revenues and the total number of centers in operation per available statistics. As of September 30, 2010, the Company operated a network of 111 centers with 64 hospital partners, spanning 41 cities and 23 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipments and manages the daily operations of these centers located on its hospital partners' premises. The Company also provides ongoing
'/>"/>

SOURCE Concord Medical Services Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Concord Medical Services Holdings to Present at Two Upcoming Conferences
2. Concord Medical to Hold Annual General Meeting on December 11, 2010
3. Concord Medical Announces Second Quarter 2010 Financial Results
4. Concord Medical to Report Second Quarter 2010 Financial Results on Wednesday, August 18, 2010
5. Concord Medical Enters into Joint Venture Agreement with ChangAn Hospital
6. Concord Medical Files 2009 Annual Report on Form 20-F
7. Concord Medical Announces Share Repurchase Program
8. Concord Medical Announces New Centers Opening at Hospital Partner
9. Concord Medical to Report First Quarter 2010 Financial Results on Thursday, May 27, 2010
10. Concord Grape Juice Has No Significant Impact on Body Weight
11. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  AMRI (NASDAQ: ... announced a strategic collaboration focused on the development, ... active pharmaceutical ingredients, ("APIs"). The collaboration combines Saneca,s ... their expertise in developing and manufacturing controlled substance ... to tech transfer processes into these facilities. The ...
(Date:8/31/2015)... August 31, 2015 Premune ... into an exclusive licensing agreement for Redonyl ® ... $300 million USD veterinary dermatology market, is a nutritional ... support healthy skin in dogs and cats. Redonyl ® ... , and has been received positively in the ...
(Date:8/31/2015)... Aug. 31, 2015  QT Vascular Ltd., together with its ... with its subsidiaries, the "Group"), a global company ... advanced therapeutic solutions for the minimally invasive treatment ... of the below-the-knee ("BTK") cohort of patients in ... presented on August 15, 2015 at the 5th ...
Breaking Medicine Technology:AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... , April 29, 2010 Albireo today,announced ... recent study,assessing the safety, tolerability and efficacy of A3309 ... compound for,the treatment of irritable bowel syndrome with constipation ... during the 2010,Digestive Disease Week (DDW) annual meeting being ...
... SALT LAKE CITY , April 28 Sonic Innovations, ... Administration (VA), is conducting ongoing training events for government clinicians.  The company ... in San Diego, California and April 25 through ... for May 3 through 5 in Salt Lake City, ...
Cached Medicine Technology:Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 2Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 3Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 4Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 5Sonic Innovations Conducts National Training Events for Government Clinicians 2Sonic Innovations Conducts National Training Events for Government Clinicians 3
(Date:9/1/2015)... ... September 01, 2015 , ... Routines… every family has them. Whether ... make things easier for parents, caregivers and children too. Here are three reasons why ... and small become more fluid. When a routine is implemented into a child’s schedule, ...
(Date:9/1/2015)... IL (PRWEB) , ... September 01, 2015 , ... ... and Zeel™, has recently sponsored an educational workshop for physician assistants (PAs) practicing ... Injections of Traumeel™ and Zeel™” was held by Dr. Erick Salado, an orthopedic ...
(Date:9/1/2015)... ... 2015 , ... Specialty Technical Publishers (STP) and Specialty Technical ... (IAPC) EHS audit protocol for the European Union. Leading companies around the world ... obligations and rapidly collect, share, archive, and export audit findings in a cost-effective ...
(Date:9/1/2015)... ... September 01, 2015 , ... Curly Hair Solutions™ ... salons. This highly anticipated partnership between Curly Hair Solutions™ and Trade Secrets allows ... Jonathan Torch and the Curly Hair Solutions™ team could not be more delighted ...
(Date:8/31/2015)... ... ... The PT Outcomes Registry is an organized system for collecting data to ... is being developed by the American Physical Therapy Association (APTA). , Al Amato, PT, ... contribute FOTO Outcomes measures as one of the primary global outcomes measures to be ...
Breaking Medicine News(10 mins):Health News:Back into the Swing of Things: How Family Routines Benefit Children 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2
... Oct. 31 The Ensign,Group, Inc. (Nasdaq: ... group of,skilled nursing, rehabilitative care services and assisted ... the Oppenheimer &,Co. 19th Annual Healthcare Conference on ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ), Christopher Christensen, the company,s ...
... October 31, 2008 A study by ... was very useful in the diagnosis of obscure gastrointestinal ... majority of patients. The study appears in the October ... peer-reviewed scientific journal of the American Society for Gastrointestinal ...
... Data Demonstrate High, Durable Response Rates for Patients with ... ... Oct. 31 Cephalon, Inc., (Nasdaq:,CEPH) today announced that ... (bendamustine hydrochloride) for Injection for the,treatment of patients with ...
... Million Election Day Bond Referendum to,Support Water, Sewage ... Edward G.,Rendell pointed to a report issued today ... water and sewer infrastructure and,warns of an impending ... funds these systems., The report, compiled by ...
... savings ends Sunday,morning, roads may become more dangerous, says ... free driver safety films and,programs for schools and other ... weekend, the drive home from work or,school for many ... of The,National Road Safety Foundation. "The time change and ...
... 31 The Aurora Visiting Nurse,Association honored donors, ... Wisconsin during the home health and hospice agency,s ... Hospital of Wisconsin was recognized as corporate friend ... pediatric program., "The relationship between Aurora VNA ...
Cached Medicine News:Health News:The Ensign Group to Present at the Oppenheimer 19th Annual Healthcare Conference 2Health News:Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding 2Health News:Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding 3Health News:Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 2Health News:Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 3Health News:Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 4Health News:Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 5Health News:Governor's Task Force Cites PA's $36.5 Billion Water Infrastructure Need; Report Underscores Call for Additional Investments 2Health News:Governor's Task Force Cites PA's $36.5 Billion Water Infrastructure Need; Report Underscores Call for Additional Investments 3Health News:Turning Clocks Back Increases Risk of Drowsy Driving 2Health News:Aurora Visiting Nurse Association of Wisconsin Honors Supporters, Volunteers 2
Hemagglutination slide test for the qualitative and quantitative detection of Rheumatoid Factor in serum or synovial fluid....
Hemagglutination slide test for the differential qualitative detection and quantitative determination of infectious mononucleosis and other heterophile antibodies in serum or plasma....
Color-enhanced hemagglutination slide test for the rapid qualitative and semi-quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma....
... Inverness Medical Professional Diagnostics is a leading ... IFA and DFA test menu that includes ... STDs as well as miscellaneous conjugates and ... you a wide assortment of substrates and ...
Medicine Products: